Cowen And Company, LLC Syndax Pharmaceuticals Inc Put Options Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022
SELL
$14.84 - $22.15 $148,400 - $221,500
-10,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$15.23 - $22.47 $152,300 - $224,700
10,000 New
10,000 $1,000
Q4 2020

Feb 08, 2021
SELL
$15.1 - $26.44 $305,020 - $534,088
-20,200 Closed
0 $0
Q3 2020

Nov 03, 2020
SELL
$13.39 - $17.48 $332,072 - $433,504
-24,800 Reduced 55.11%
20,200 $61,000
Q2 2020

Aug 13, 2020
BUY
$8.94 - $20.98 $402,300 - $944,100
45,000 New
45,000 $96,000

Others Institutions Holding SNDX

# of Institutions
229
Shares Held
88.4M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $934M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email